Edwards Larry G. 4
Accession 0000899243-22-029657
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 8:20 PM ET
Size
64.9 KB
Accession
0000899243-22-029657
Insider Transaction Report
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−334→ 0 totalExercise: $4.27→ Common Stock (334 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−4,170→ 0 totalExercise: $4.63→ Common Stock (4,170 underlying) - Disposition to Issuer
Common Stock
2022-08-22$6.23/sh−11,969$74,567→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−320→ 0 totalExercise: $4.21→ Common Stock (320 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−278,350→ 0 totalExercise: $4.53→ Common Stock (278,350 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−322→ 0 totalExercise: $4.18→ Common Stock (322 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−304→ 0 totalExercise: $4.44→ Common Stock (304 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−314→ 0 totalExercise: $4.30→ Common Stock (314 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−400,000→ 0 totalExercise: $3.89→ Common Stock (400,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−275→ 0 totalExercise: $4.90→ Common Stock (275 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−338→ 0 totalExercise: $3.98→ Common Stock (338 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−358→ 0 totalExercise: $3.76→ Common Stock (358 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−315→ 0 totalExercise: $4.28→ Common Stock (315 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−374→ 0 totalExercise: $3.61→ Common Stock (374 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−233→ 0 totalExercise: $4.61→ Common Stock (233 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−358→ 0 totalExercise: $3.76→ Common Stock (358 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−335→ 0 totalExercise: $4.02→ Common Stock (335 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−676→ 0 totalExercise: $3.99→ Common Stock (676 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−361→ 0 totalExercise: $3.96→ Common Stock (361 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−296→ 0 totalExercise: $4.37→ Common Stock (296 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−341→ 0 totalExercise: $3.96→ Common Stock (341 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−336→ 0 totalExercise: $4.01→ Common Stock (336 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−346→ 0 totalExercise: $3.90→ Common Stock (346 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−320→ 0 totalExercise: $4.21→ Common Stock (320 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−418,944→ 0 totalExercise: $4.81→ Common Stock (418,944 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−273→ 0 totalExercise: $4.92→ Common Stock (273 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−320→ 0 totalExercise: $4.46→ Common Stock (320 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-22−350→ 0 totalExercise: $4.09→ Common Stock (350 underlying)
Footnotes (2)
- [F1]This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 10, 2022, by and among the Issuer, Innoviva, Inc., a Delaware corporation ("Parent"), and Innoviva Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent ("Purchaser"), to which Purchaser completed a tender offer for shares of common stock of the Issuer, $0.0001 par value per share (each, a "Share"), and thereafter merged with and into the Issuer (the "Merger") effective as of August 22, 2022 (the "Effective Time"). At the Effective Time, each issued and outstanding Share was converted into the right to receive $6.23 per Share, in cash, without interest (the "Offer Price") and subject to any withholding of taxes, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled.
- [F2]Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an "Issuer Stock Option") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Offer Price over the exercise price payable per Share with respect to such Issuer Stock Option.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Related Parties
1- filerCIK 0001733062
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 8:20 PM ET
- Size
- 64.9 KB